Acceleron Pharma (XLRN)

178.75  -0.93 (-0.52%)

After market: 179.92 +1.17 (+0.65%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
13.99M
3.78%		73.99M
428.88%		92.52M
25.04%		139.562M
EBITDA
YoY % growth
-120.66M
-12.61%		-132.51M
-9.82%		-163.46M
-23.36%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-124.41M
-13.12%		-136.45M
-9.68%		-167.31M
-22.62%		N/AN/AN/AN/AN/A
Operating Margin
-889.28%-184.42%-180.84%N/AN/AN/AN/AN/A
EPS
YoY % growth
-2.59
0.77%		-2.38
8.11%		-2.90
-21.85%		-4.11

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.91
Revenue
Q2Q % growth		45.41M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q3 2021
Q2Q % growth		 -1.16
-75.76%		-1.01-0.15-15.29%
Q2 2021
Q2Q % growth		 -1.05
-208.82%		-0.89-0.16-18.23%
Q1 2021
Q2Q % growth		 -1.05
-10.53%		-0.83-0.22-26.32%
Q4 2020
Q2Q % growth		 -0.95
-115.91%		-0.60-0.35-59.04%
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q3 2021
Q2Q % growth		 34.199M
51.59%		35.83M-1.631M-4.55%
Q2 2021
Q2Q % growth		 27.94M
-29.71%		31.413M-3.473M-11.06%
Q1 2021
Q2Q % growth		 24.76M
470.51%		29.464M-4.704M-15.96%
Q4 2020
Q2Q % growth		 25.87M
-34.24%		32.953M-7.083M-21.49%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A